|
Market Closed -
Euronext Paris
11:55:00 2026-10-14 EDT
|
5-day change | 1st Jan Change | ||
| 0.4080 EUR | -4.56% |
|
-25.68% | +195.65% |
| 10-12 | Valerio Therapeutics Finalizes Purchase of Etherna Immunotherapies | MT |
| 10-07 | Valerio Therapeutics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 239M | - | - | - | - | - |
| 1,040B | |||||
| 599B | |||||
| 485B | |||||
| 350B | |||||
| 345B |
- Stock Market
- Stocks
- ALVIO Stock
- Charts Valerio Therapeutics
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
